Results 251 to 260 of about 176,622 (333)

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

International Journal of Cancer, Volume 158, Issue 2, Page 382-408, 15 January 2026.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner, Tobias Berg, Daniel Sasca, Sophie‐Luise Mersiowsky, Jayant Y. Gadrey, Johanna Thomas, Michael W. M. Kühn, Michael Lübbert   +7 more
wiley   +1 more source

Esophageal perforation in a patient with lung cancer after administration of bevacizumab combined with radiotherapy and chemotherapy: A case report. [PDF]

Oncol Lett
Jia Q, Zhou YL, Duan LY, Li HC, Hu G.
europepmc   +1 more source

Recent developments in eosinophilic renal neoplasms: what's new, true and important?

Histopathology, Volume 88, Issue 1, Page 166-192, January 2026.
Recent developments and acquired knowledge on newer renal entities with eosinophilic cytoplasm opened insights into the clinical, pathological, immunohistochemical, molecular, epidemiological aspects, and the prognosis of these entities. We emphasize the role of routine morphology, aided by appropriate and select immunohistochemistry, as essential keys
Kiril Trpkov, Farshid Siadat, Rola Saleeb   +2 more
wiley   +1 more source

Role of Angiogenesis in Retinal Diseases and New Advances in Drug Development. [PDF]

Cells
Boey E, Zaidi H, Tang T, Yazdanyar A.
europepmc   +1 more source

Advances in non‐germ cell tumours of the testis: focus on new molecular developments in sex cord‐stromal tumours

Histopathology, Volume 88, Issue 1, Page 230-251, January 2026.
In this review, we summarise the major recent advances in Testicular Sex Cord‐Stromal Tumours, focusing on molecular alterations and biomarkers relevant for diagnosis, classification and prognosis. Testicular sex cord‐stromal tumours (TSCSTs) represent ~4%–8% of all testicular neoplasms.
João Lobo, Andres M Acosta
wiley   +1 more source

Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child–Pugh Class B

Liver International, Volume 46, Issue 1, January 2026.
ABSTRACT Background & Aims Despite the advances in systemic therapy for unresectable hepatocellular carcinoma (HCC), patients with Child–Pugh class B (CP‐B) liver function face a significant unmet need. This study evaluated the efficacy and safety of atezolizumab plus bevacizumab (Atez/Bev) in patients with unresectable HCC and CP‐B.
Ryu Sasaki, Shigeo Shimose, Issei Saeki, Takanori Ito, Yasuto Takeuchi, Joji Tani, Tetsu Tomonari, Kyo Sasaki, Satoru Kakizaki, Takeshi Hatanaka, Satoshi Miuma, Tomotake Shirono, Hideki Iwamoto, Norikazu Tanabe, Takafumi Yamamoto, Yuki Kanayama, Atsushi Naganuma, Sohji Nishina, Tetsuji Takayama, Hideki Kobara, Motoyuki Otsuka, Hiroki Kawashima, Taro Takami, Takumi Kawaguchi, Hisamitsu Miyaaki, Hepatology InVestigator Experts in Japan (HIVE‐J) Study Group   +25 more
wiley   +1 more source

Aflibercept, ranibizumab, and bevacizumab for macular neovascularization secondary to age-related macular degeneration: a retrospective OCT-angiography study. [PDF]

Int J Retina Vitreous
Lombardo M, Maccauro C, D'Ambrosio M, Grossi M, Missiroli F, Cesareo M, Ricci F.   +6 more
europepmc   +1 more source

Macular OCT findings in ROP patients treated with both laser and bevacizumab

, 2012
Cristina Santos, Rmg Azevedo, S Pina, Susana Teixeira, Adriana Melo   +4 more
openalex   +1 more source

Clinical Efficacy and Safety of Intralesional Bevacizumab in Dermatology: Insights from a Systematic Review. [PDF]

Dermatol Pract Concept
Rastegarnasab F, Tavousi N, Pourmahdi-Boroujeni M, Afshar K, Behfar S, Abtahi-Naeini B.   +5 more
europepmc   +1 more source